BioCentury | Jan 11, 2021
Deals

Atopic dermatitis readout drives Sanofi’s $1.1B takeout of Kymab

...in a Phase IIb study to treat atopic dermatitis. Ichnos was spun out of Mumbai-based Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...Ramasastry joined the board. She serves on the boards of Vir Biotechnology Inc. (NASDAQ:VIR), Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Jul 3, 2020
Deals

July 2 Quick Takes: Novartis to ante up $678M in settlement; plus Zai, Neoleukin, Base Genomics, Sarepta-Hansa, Dr. Reddy-Fujifilm

...an undisclosed upfront license fee and royalties. In June, India approved generic favipiravir from Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Jun 26, 2020
Product Development

Gilead goes for lung delivery of remdesivir, earlier COVID-19 disease stage

...and Hetero Drugs Ltd. The agency also approved on June 20 favipiravir tablets from Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...will map out factors that are critical for virus replication. Glenmark starts Indian trial Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
...factor receptor tyrosine kinase Elizabeth S. Eaton, Staff Writer mRNA-1273 remdesivir, GS-5734 Avigan, favipiravir (T-705) Gilead Sciences Inc. Innovative Medicines Initiative (IMI) Glenmark Pharmaceuticals Ltd. Fujifilm...
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...Venkat Reddy as CSO. Reddy was SVP and global head of translational sciences at Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Oct 7, 2019
Company News

Gilead fills CMO spot with Genentech exec Parsey

...of Oncology Therapeutics Alessandro Riva left to become CEO of the innovation business at Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Aug 12, 2019
Company News

Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

...company Mesoblast Ltd. (ASX:MSB; NASDAQ:MESO) hired Fred Grossman as CMO. He was CMO of Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Jul 17, 2019
Company News

Gilead CSO McHutchison, two others, out as O’Day reshapes his team

...leave since March. Former EVP of Oncology Therapeutics Alessandro Riva left to become CEO of Glenmark’s...
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...letter for Gimoti intranasal metoclopramide to treat acute and recurrent diabetic gastroparesis in women Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
Items per page:
1 - 10 of 129
BioCentury | Jan 11, 2021
Deals

Atopic dermatitis readout drives Sanofi’s $1.1B takeout of Kymab

...in a Phase IIb study to treat atopic dermatitis. Ichnos was spun out of Mumbai-based Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...Ramasastry joined the board. She serves on the boards of Vir Biotechnology Inc. (NASDAQ:VIR), Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Jul 3, 2020
Deals

July 2 Quick Takes: Novartis to ante up $678M in settlement; plus Zai, Neoleukin, Base Genomics, Sarepta-Hansa, Dr. Reddy-Fujifilm

...an undisclosed upfront license fee and royalties. In June, India approved generic favipiravir from Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Jun 26, 2020
Product Development

Gilead goes for lung delivery of remdesivir, earlier COVID-19 disease stage

...and Hetero Drugs Ltd. The agency also approved on June 20 favipiravir tablets from Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...will map out factors that are critical for virus replication. Glenmark starts Indian trial Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
...factor receptor tyrosine kinase Elizabeth S. Eaton, Staff Writer mRNA-1273 remdesivir, GS-5734 Avigan, favipiravir (T-705) Gilead Sciences Inc. Innovative Medicines Initiative (IMI) Glenmark Pharmaceuticals Ltd. Fujifilm...
BioCentury | Jan 10, 2020
Company News

Management tracks: COO, CMO depart as Solid restructures; plus Abeona, Millendo, Immuneering, Akouos, Kintai, Macrophage, Selexis, Prime

...Venkat Reddy as CSO. Reddy was SVP and global head of translational sciences at Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Oct 7, 2019
Company News

Gilead fills CMO spot with Genentech exec Parsey

...of Oncology Therapeutics Alessandro Riva left to become CEO of the innovation business at Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Aug 12, 2019
Company News

Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

...company Mesoblast Ltd. (ASX:MSB; NASDAQ:MESO) hired Fred Grossman as CMO. He was CMO of Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
BioCentury | Jul 17, 2019
Company News

Gilead CSO McHutchison, two others, out as O’Day reshapes his team

...leave since March. Former EVP of Oncology Therapeutics Alessandro Riva left to become CEO of Glenmark’s...
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...letter for Gimoti intranasal metoclopramide to treat acute and recurrent diabetic gastroparesis in women Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK...
Items per page:
1 - 10 of 129